NO961778L - Fremgangsmåte for behandling ved anvendelse av unilamelære liposomale arachidonsyremetabolitt formuleringer - Google Patents
Fremgangsmåte for behandling ved anvendelse av unilamelære liposomale arachidonsyremetabolitt formuleringerInfo
- Publication number
- NO961778L NO961778L NO961778A NO961778A NO961778L NO 961778 L NO961778 L NO 961778L NO 961778 A NO961778 A NO 961778A NO 961778 A NO961778 A NO 961778A NO 961778 L NO961778 L NO 961778L
- Authority
- NO
- Norway
- Prior art keywords
- arachidonic acid
- treatment
- acid metabolite
- unilamellar liposomal
- prostaglandins
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
- A61K9/1278—Post-loading, e.g. by ion or pH gradient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14789893A | 1993-11-04 | 1993-11-04 | |
US15285293A | 1993-11-16 | 1993-11-16 | |
US18008994A | 1994-01-11 | 1994-01-11 | |
PCT/US1994/012579 WO1995012388A1 (en) | 1993-11-04 | 1994-11-03 | Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations |
Publications (3)
Publication Number | Publication Date |
---|---|
NO961778D0 NO961778D0 (no) | 1996-05-02 |
NO961778L true NO961778L (no) | 1996-06-25 |
NO312809B1 NO312809B1 (no) | 2002-07-08 |
Family
ID=27386612
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19961779A NO312810B1 (no) | 1993-11-04 | 1996-05-02 | Multilamell¶r liposomal arachidonsyre metabolitt formuleringer og en fremgangsmåte for fremstilling av etmedikament derav |
NO19961778A NO312809B1 (no) | 1993-11-04 | 1996-05-02 | Fremgangsmåter for fremstilling av en farmasöytisk sammensetning ved anvendelse av unilamell¶re liposomalearachidonsyremetabolitt formuleringer samt anvendelse derav |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19961779A NO312810B1 (no) | 1993-11-04 | 1996-05-02 | Multilamell¶r liposomal arachidonsyre metabolitt formuleringer og en fremgangsmåte for fremstilling av etmedikament derav |
Country Status (13)
Country | Link |
---|---|
EP (2) | EP0726764B1 (no) |
JP (2) | JPH09511216A (no) |
KR (2) | KR100355246B1 (no) |
AT (2) | ATE191141T1 (no) |
AU (2) | AU687921B2 (no) |
CA (2) | CA2175896A1 (no) |
DE (2) | DE69423773T2 (no) |
DK (2) | DK0726763T3 (no) |
ES (2) | ES2136271T3 (no) |
GR (2) | GR3032006T3 (no) |
NO (2) | NO312810B1 (no) |
PT (1) | PT726763E (no) |
WO (2) | WO1995012389A1 (no) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6747027B1 (en) | 1996-07-22 | 2004-06-08 | Pharmacia Corporation | Thiol sulfonamide metalloprotease inhibitors |
ATE233552T1 (de) * | 1996-07-22 | 2003-03-15 | Monsanto Co | Thiol-sulfonen als metalloproteinaseinhibitoren |
US6362183B1 (en) | 1997-03-04 | 2002-03-26 | G. D. Searle & Company | Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
WO1998039316A1 (en) | 1997-03-04 | 1998-09-11 | Monsanto Company | N-hydroxy 4-sulfonyl butanamide compounds |
WO1998039315A1 (en) | 1997-03-04 | 1998-09-11 | Monsanto Company | Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
WO1999025687A1 (en) | 1997-11-14 | 1999-05-27 | G.D. Searle & Co. | Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
US20010039287A1 (en) | 1997-11-14 | 2001-11-08 | Thomas E Barta | Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
US6750228B1 (en) | 1997-11-14 | 2004-06-15 | Pharmacia Corporation | Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
KR20010102000A (ko) | 1999-02-08 | 2001-11-15 | 윌리암스 로저 에이 | 술파마토 히드록삼산 메탈로프로테아제 억제제 |
US6583299B1 (en) | 1999-05-20 | 2003-06-24 | G.D. Searle & Co. | α-amino-β-sulfonyl hydroxamic acid compounds |
US6683078B2 (en) | 2001-07-19 | 2004-01-27 | Pharmacia Corporation | Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
JP2003342196A (ja) * | 2002-05-31 | 2003-12-03 | Mukku:Kk | 静脈注射用組成物、その製造法およびその製剤 |
WO2013039851A1 (en) | 2011-09-12 | 2013-03-21 | Mallinckrodt Llc | Optical agents for imaging and visualization of matrix metalloproteinase enzymes |
CN111053743B (zh) * | 2018-10-16 | 2023-07-14 | 石药集团中奇制药技术(石家庄)有限公司 | 一种前列地尔脂质体及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5262168A (en) * | 1987-05-22 | 1993-11-16 | The Liposome Company, Inc. | Prostaglandin-lipid formulations |
WO1988009170A1 (en) * | 1987-05-22 | 1988-12-01 | The Liposome Company, Inc. | Prostaglandin-lipid formulations |
JPH0395118A (ja) * | 1989-09-07 | 1991-04-19 | Green Cross Corp:The | プロスタグランジン含有脂肪小体製剤 |
JPH04356421A (ja) * | 1991-03-06 | 1992-12-10 | Green Cross Corp:The | プロスタグランジン類含有脂肪小体組成物 |
ES2128343T3 (es) * | 1991-05-07 | 1999-05-16 | Liposome Co Inc | Formulaciones de prostaglandina liposomica. |
JPH05139977A (ja) * | 1991-05-17 | 1993-06-08 | Green Cross Corp:The | プロスタグランジン類リポソーム複合体を充填した注射器 |
-
1994
- 1994-11-03 AU AU81326/94A patent/AU687921B2/en not_active Ceased
- 1994-11-03 CA CA002175896A patent/CA2175896A1/en not_active Abandoned
- 1994-11-03 PT PT95900504T patent/PT726763E/pt unknown
- 1994-11-03 DE DE69423773T patent/DE69423773T2/de not_active Expired - Fee Related
- 1994-11-03 DE DE69420859T patent/DE69420859T2/de not_active Expired - Fee Related
- 1994-11-03 WO PCT/US1994/012710 patent/WO1995012389A1/en active IP Right Grant
- 1994-11-03 EP EP95900532A patent/EP0726764B1/en not_active Expired - Lifetime
- 1994-11-03 EP EP95900504A patent/EP0726763B1/en not_active Expired - Lifetime
- 1994-11-03 CA CA002175057A patent/CA2175057A1/en not_active Abandoned
- 1994-11-03 KR KR1019960702299A patent/KR100355246B1/ko not_active IP Right Cessation
- 1994-11-03 ES ES95900532T patent/ES2136271T3/es not_active Expired - Lifetime
- 1994-11-03 AU AU81308/94A patent/AU8130894A/en not_active Abandoned
- 1994-11-03 DK DK95900504T patent/DK0726763T3/da active
- 1994-11-03 AT AT95900504T patent/ATE191141T1/de not_active IP Right Cessation
- 1994-11-03 JP JP7513378A patent/JPH09511216A/ja active Pending
- 1994-11-03 AT AT95900532T patent/ATE184785T1/de not_active IP Right Cessation
- 1994-11-03 KR KR1019960702298A patent/KR100355247B1/ko not_active IP Right Cessation
- 1994-11-03 ES ES95900504T patent/ES2144118T3/es not_active Expired - Lifetime
- 1994-11-03 DK DK95900532T patent/DK0726764T3/da active
- 1994-11-03 JP JP7513436A patent/JPH09504793A/ja not_active Abandoned
- 1994-11-03 WO PCT/US1994/012579 patent/WO1995012388A1/en active IP Right Grant
-
1996
- 1996-05-02 NO NO19961779A patent/NO312810B1/no not_active IP Right Cessation
- 1996-05-02 NO NO19961778A patent/NO312809B1/no not_active IP Right Cessation
-
1999
- 1999-11-30 GR GR990403099T patent/GR3032006T3/el unknown
-
2000
- 2000-06-29 GR GR20000401517T patent/GR3033817T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO961778D0 (no) | Fremgangsmåte for behandling ved anvendelse av unilamelære liposomale arachidonsyre metabolit formuleringer | |
ES2180635T3 (es) | Metodo para reducir la grasa corporal en animales mediante la administracion de acido linoleico conjugado. | |
EA200100721A1 (ru) | Производное габапентина для предупреждения и лечения висцеральной боли | |
NO303816B1 (no) | Vandig retinoid-gelblanding | |
AR013488A1 (es) | COMPOSICIoN GERMICIDA ACUOSA PARA EL TRATAMIENTO O PREVENCIoN DE ENFERMEDADES INFECCIOSAS DE LAS PEZUNAS DE ANIMALES, Y USO DE DICHA COMPOSICIoN | |
ES2164434T3 (es) | Tratamiento topico de psoriasis que utiliza anticuerpos neutralizantes de il-8. | |
ES2148593T3 (es) | Compuestos retinoides trienoicos novedosos y metodos. | |
DE59805245D1 (de) | Wässrige pflegende haut- und haarbehandlungsmittel | |
ES2161247T3 (es) | Preparacion vaginal que contiene un peptido fisiologicamente activo. | |
WO2002036090A3 (de) | Kosmetische pflaster zur hautaufhellung | |
ES2162410T3 (es) | Uso de alcohol diclorobencilico para hacer una preparacion para tratamiento topico de inflamacion. | |
ES2126868T3 (es) | Liposomas de fusion por interdigitacion que contienen metabolitos de acido araquidonico. | |
AR019893A1 (es) | Un metodo para reducir o evitar el mal olor | |
YU31104A (sh) | Inhibicija virusa n-dokozanolom | |
FI910308A0 (fi) | Vattenloesliga vitamin a preparationer foer applicering pao huden. | |
DE69722178D1 (de) | Therapeutischer wirkstoff für augenerkrankungen | |
KR950700685A (ko) | 최음제로서 사용되는 요드화수소산(use of hydriodic acid as an aphrodisiac) | |
NO20032035L (no) | Terapeutiske midler for keratokonjuktivitis sykdommer omfattende farnesyleddiksyre som aktiv ingrediens | |
IT8026351A0 (it) | Derivato della ammino-penicillina, processo per la sua preparazione e composizioni terapeutiche che lo comprendono come principio attivo. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |